NCT04867252View on ClinicalTrials.gov

Effects of Combined Resveratrol and Myo-inositol on Altered Metabolic, Endocrine Parameters and Perceived Stress in Patients With Polycystic Ovarian Syndrome

PHASE2CompletedINTERVENTIONAL
Enrollment

88

Participants

Timeline

Start Date

May 3, 2021

Primary Completion Date

August 3, 2021

Study Completion Date

August 3, 2021

Conditions
PCOS
Interventions
DRUG

Resveratrol (1000mg twice a day), Myoinositol 1000mg (Twice a day)

51 Patients with PCOS receiving Resveratrol and Myoinositol 1000mg and 1000mg BD daily respectively

DRUG

Metformin (500 mg Twice a day), Pioglitazone (15 mg Twice a day)

51 Patients with PCOS receiving Metformin and Pioglitazone 500 mg and 15 mg BD daily respectively

Trial Locations (1)

25000

Gynecology and Obstetric, Hayatabad Medical Complex, Peshawar

All Listed Sponsors
lead

Khyber Medical University Peshawar

OTHER